Cardiovascular
0 drugs are in development for Resistant Hypertension.
- Companies
- 0
- Clinical trials
- 5
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Resistant Hypertension pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
About this indication
Resistant Hypertension context
Cardiovascular·MeSH: Hypertension (D006973)
Narrower concept of MeSH descriptor Hypertension
Prevalence
47000.0 / 100K
Incidence
3000.0 / 100K/yr
Frequently asked questions
How many clinical trials target Resistant Hypertension?
There are 5 clinical trials targeting Resistant Hypertension tracked by BioSniper.
What is the prevalence of Resistant Hypertension?
The estimated prevalence of Resistant Hypertension is approximately 47000.0 per 100,000 population.